a2 Milk Company earnings date
a2 Milk Company (A2M) Q4 2026 Earnings Report
AU:A2M Q4 2026 EPS Results
- Actual EPS
- AUD 0.11
- Consensus EPS
- AUD 0.11
- Beat/Miss
- Beat by +AUD 0.00
- One Year Ago EPS
- AUD 0.13
AU:A2M Q4 2026 Revenue Results
- Actual Revenue
- AUD 806.88M
- Expected Revenue
- AUD 800.44M
- Beat/Miss
- Beat by +AUD 6.44M
- YoY Revenue Growth
- -2.66%
Earnings Announcement Details
- Quarter
- Q4 2026
- Date
- 08/16/2026
- Time
- After Close
- Conference Call
- Sunday, August 16, 2026
a2 Milk Company's next earnings date is estimated for February 22, 2027, based on past reporting schedules.
Q4 2026 Earnings Call Audio
Q4 2026 Earnings Slide Deck
Q4 2026 Earnings Call Summary
The call presented a mixed picture: the company delivered strong top-line growth (+12.4%), solid underlying EBITDA and multiple growth vectors (U.S., ANZ, other nutritionals, innovation), completed strategic supply-chain moves (a2 Pokeno) and returned significant capital to shareholders. However, a material fourth-quarter supply-chain disruption severely impacted China label IMF sales and in-market availability, pressured reported margins and required elevated marketing and recovery spend. Management outlined a clear recovery plan and expects FY'27 growth weighted to the second half, but near-term margin and sales phasing remain challenged.
The company guided FY27 to mid‑single‑digit revenue growth with first‑half revenue broadly in line with FY26 and group revenue and EBITDA materially weighted to the second half; it expects EBITDA margin of approximately 15% (versus FY25 EBITDA margin of 16.6% and FY26 underlying margin of 15.6%), with most of the ~1.6 percentage‑point year‑on‑year decline driven by gross‑margin headwinds (mix dilution as IMF is broadly flat while liquid milk and other nutritionals grow, plus higher milk/ingredient COGS) and a higher marketing reinvestment profile (phased into H1, roughly ~2 percentage points higher reinvestment in H1), IMF sales to be impacted by Q4 supply‑chain flow‑on effects with a gradual recovery over the year supported by increased marketing, and a2 Pokeno expected to reach EBITDA breakeven in FY27.
- Revenue GrowthGroup revenue increased 12.4% year-on-year to approximately $1.97 billion (FY'26), driven by broad-based growth across geographies and product categories.
- Underlying EBITDA and Earnings ImprovementUnderlying EBITDA (excluding a2 Pokeno) rose 5.4% to $307.6 million with an underlying EBITDA margin of 15.6%. Underlying net profit after tax and underlying EPS increased by ~7%.
- Strong Regional Performance — U.S. and ANZU.S. net sales revenue grew ~29% to $179 million and achieved EBITDA breakeven in H2 for the first time. ANZ delivered double-digit revenue growth (Australia liquid milk revenue up 17% to $245 million) and gained retail shares (overall share to 11.7%; lactose-free share to 22.6%).
- Category Strength — Other Nutritionals and Liquid MilkOther nutritionals delivered substantial growth (cited as +42% excluding a2 Pokeno; separately noted nearly 60% to $216 million led by kids and seniors products). Liquid milk grew strongly (~22% quoted) and outperformed markets.
- Innovation Contribution and Product PipelineNew product launches accounted for more than 50% of FY'26 sales growth. Product portfolio expanded from 8 categories/markets in FY'21 to a planned 36 by end-FY'27; further launches and formulation upgrades (a2 Platinum and a2 Genesis) planned in FY'27.
- Supply Chain Transformation — a2 Pokeno AcquisitionCompleted acquisition of a2 Pokeno, commenced capital upgrades on time and on budget, doubled the Pokeno team, secured China label registration amendments; site on track for EBITDA breakeven in FY'27 and will in-source a2 Platinum to capture vertical margin.
- Capital Management and DividendsDeclared total ordinary and special dividends of $453 million for FY'26, including a $300 million special dividend and an increased ordinary dividend (final dividend $0.095 per share; payout ratio ~74%).
- Strong Balance Sheet and LiquidityClosing cash and term deposits of $784.5 million, no external debt and a balance sheet positioned to support growth and supply chain investment.
AU:A2M Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 22, 2027 | 2027 (Q2) | 0.11- | 0.14 | ― | ― |
| Aug 16, 2026 | 2026 (Q4) | 0.110.11 | 0.13 | -14.38% (-0.02) | |
| Feb 15, 2026 | 2026 (Q2) | 0.120.14 | 0.1 | 33.07% (+0.03) | |
| Aug 17, 2025 | 2025 (Q4) | 0.120.13 | 0.09 | 34.21% (+0.03) | |
| Feb 16, 2025 | 2025 (Q2) | 0.090.10 | 0.1 | 7.63% (+0.01) | |
| Aug 18, 2024 | 2024 (Q4) | 0.100.09 | 0.09 | 0.88% (+0.00) | |
| Feb 18, 2024 | 2024 (Q2) | 0.080.10 | 0.08 | 19.19% (+0.02) | |
| Aug 20, 2023 | 2023 (Q4) | 0.080.09 | 0.07 | 32.94% (+0.02) | |
| Feb 19, 2023 | 2023 (Q2) | 0.080.08 | 0.07 | 23.75% (+0.02) | |
| Aug 28, 2022 | 2022 (Q4) | 0.090.07 | -0.04 | 293.18% (+0.11) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


